IgA structure variations associate with immune stimulations and IgA mesangial deposition

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2748-2761

  Oruc, Zeliha ^a   Oblet, Christelle ^a   Boumediene, Ahmed ^a   Druilhe, Anne ^a   Pascal, Virginie ^a   Le Rumeur, Elisabeth ^b   Cuvillier, Armelle ^c   El Hamel, Chahrazed ^a   Lecardeur, Sandrine ^a   Leanderson, Tomas ^d   Morelle, Willy ^e   Demengeot, Jocelyne ^f   Aldigier, Jean Claude ^a   Cogné, Michel ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c B Cell Design   (France)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^f INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PODOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; FEMALE; GENETIC BACKGROUND; GLYCOSYLATION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; IMMUNOSTIMULATION; LECTIN BINDING; MALE; MESANGIUM; MOLECULAR WEIGHT; MOUSE; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ELECTROPHORESIS; ANIMAL; ANTIBODY PRODUCTION; IMMUNOLOGY; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; ANTIBODY FORMATION; FEMALE; GLOMERULAR MESANGIUM; IMMUNOGLOBULIN A; MALE; MICE; PROTEIN CONFORMATION;

EID: 85016255070     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015080911     Document Type: Article

References (47)

1. Donadio JV,Grande JP: IgA nephropathy. N Engl J Med 347: 738-748, 2002
2. Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J, Nagata M, Yoh K, Yamagata K, Muro K, Kobayashi M, Ohtani K, Shimizu T, Shimizu T: Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 66: 121-132, 2004
3. O'Donoghue DJ, Darvill A, Ballardie FW: Mesangial cell autoantigens in immunoglobulin A nephropathy and Henoch-Schönlein purpura. J Clin Invest 88: 1522-1530, 1991
4. Lai KN, Chui SH, Lewis WH, Poon AS, Lam CW: Charge distribution of IgA-lambda in IgA nephropathy. Nephron 66: 38-44, 1994
5. Leung JC, Tang SC, Lam MF, Chan TM, Lai KN: Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int 59: 277-285, 2001
6. Suen KK, Lewis WH, Lai KN: Analysis of charge distribution of lambdaand kappa-IgA in IgA nephropathy by focused antigen capture immunoassay. Scand J Urol Nephrol 31: 289-293, 1997
7. Coppo R, Feehally J, Glassock RJ: IgA nephropathy at two score and one. Kidney Int 77: 181-186, 2010
8. Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, HuangW-Q, Anreddy SR,Hall S,HastingsMC, Lau KK, CookWJ,Novak J: Patients with IgA nephropathy have increased serum galactosedeficient IgA1 levels. Kidney Int 71: 1148-1154, 2007
9. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA: Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J AmSocNephrol 19: 1008-1014, 2008
10. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J: Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81, 1999
11. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J: Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119: 1668-1677, 2009
12. Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura AB: Spontaneous glomerular IgA deposition in ddY mice: An animal model of IgA nephritis. Kidney Int 27: 756-761, 1985
13. Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC: Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenicmice. J ExpMed 191: 1999-2009, 2000
14. Otani M, Nakata J, Kihara M, LeroyV,Moll S,Wada Y, Izui S:O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis. J Am Soc Nephrol 23: 438-446, 2012
15. Duchez S, Amin R, Cogné N, Delpy L, Sirac C, Pascal V, Corthésy B, Cogné M: Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci U S A 107: 3064-3069, 2010
16. Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PHM, Tamouza H, Jamin A, Bex-Coudrat J, Gestin A, Boumediene A, Arcos-Fajardo M, England P, Pillebout E, Walker F, Daugas E, Vrtosvnik F, Flamant M, Benhamou M, Cogné M, Moura IC, Monteiro RC: Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med 209: 793-806, 2012
17. Bonaud A, Bender S, Touchard G, Lacombe C, Srour N, Delpy L, Oblet C, Druilhe A, Quellard N, Javaugue V, Cogné M, Bridoux F, Sirac C: A mouse model recapitulating human monoclonal heavy chain deposition disease evidences the relevance of proteasome inhibitor therapy. Blood 126: 757-765, 2015
18. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J: Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int 60: 969-973, 2001
19. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K: Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59: 1077-1085, 2001
20. Varis J, Rantala I, Pasternack A,Oksa H, JänttiM, Paunu ES, Pirhonen R: Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol 46: 607-610, 1993
21. Suzuki K,Honda K, Tanabe K, Toma H, NiheiH, Yamaguchi Y: Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 63: 2286-2294, 2003
22. GarrettWS, Gordon JI, Glimcher LH: Homeostasis and inflammation in the intestine. Cell 140: 859-870, 2010
23. Hooper LV, Macpherson AJ: Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10: 159-169, 2010
24. RescignoM,Di Sabatino A: Dendritic cells in intestinal homeostasis and disease. J Clin Invest 119: 2441-2450, 2009
25. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N: The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31: 677-689, 2009
26. Boumediene A, Oblet C, Oruc Z, Duchez S, Morelle W, Huynh A, Pourrat J, Aldigier JC, Cogné M: Gammopathy with IgA mesangial deposition provides a monoclonal model of IgA nephritogenicity and offers new insights into its molecular mechanisms. Nephrol Dial Transplant 26: 3930-3937, 2011
27. Monteiro RC, Chevailler A, Noel LH, Lesavre P: SerumIgApreferentially binds to cationic polypeptides in IgA nephropathy. Clin Exp Immunol 73: 300-306, 1988
28. Zickerman AM, Allen AC, Talwar V, Olczak SA, Brownlee A, Holland M, Furness PN, Brunskill NJ, Feehally J: IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis 36: E19, 2000
29. Coppo R, Amore A, Roccatello D: Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2[Suppl]: S173-S180, 1992
30. Sategna-Guidetti C, Ferfoglia G, Bruno M, Pulitano R, Roccatello D, Amore A, Coppo R: Do IgA antigliadin and IgA antiendomysium antibodies showthere is latent coeliac disease in primary IgA nephropathy? Gut 33: 476-478, 1992
31. Coppo R, Amore A, Gianoglio B, Reyna A, Peruzzi L, Roccatello D, Alessi D, Sena LM: Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib Nephrol 104: 162-171, 1993
32. Novak J, TomanaM,Matousovic K, Brown R, Hall S,Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67: 504-513, 2005
33. Novak J: Induction of IgA deposits and glomerulonephritis by IgA rheumatoid factor. J Am Soc Nephrol 23: 371-373, 2012
34. Novak J, Julian BA,Mestecky J, Renfrow MB:Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34: 365-382, 2012
35. Erlandsson L, Andersson K, Sigvardsson M, Lycke N, Leanderson T: Mice with an inactivated joining chain locus have perturbed IgM secretion. Eur J Immunol 28: 2355-2365, 1998
36. Bridoux F, Desport E, Frémeaux-Bacchi V, Chong CF, Gombert J-M, Lacombe C,Quellard N, Touchard G: Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: A fortuitous association? Clin J Am Soc Nephrol 6: 2165-2174, 2011
37. Sandin C, Linse S, Areschoug T, Woof JM, Reinholdt J, Lindahl G: Isolation and detection of human IgAusing a streptococcal IgA-binding peptide. J Immunol 169: 1357-1364, 2002
38. Allen AC, Harper SJ, Feehally J: Galactosylation of N-and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100: 470-474, 1995
39. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J: Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52: 509-516, 1997
40. Morelle W, Michalski J-C: Analysis of protein glycosylation by mass spectrometry. Nat Protoc 2: 1585-1602, 2007
41. Faid V, Evjen G, Tollersrud O-K,Michalski J-C, MorelleW: Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase. Glycobiology 16: 440-461, 2006
42. Morelle W, Faid V, Chirat F, Michalski J-C: Analysis of N-and O-linked glycans from glycoproteins using MALDi-TOF mass spectrometry. Methods Mol Biol 534: 5-21, 2009
43. Nam CH, Moutel S, Teillaud J-L: Generation of murine scFv intrabodies from B-cell hybridomas. Methods Mol Biol 193: 301-327, 2002
44. Yuan X, Gubbins MJ, Berry JD: A simple and rapid protocol for the sequence determination of functional kappa light chain cDNAs from aberrant-chain-positive murine hybridomas. J Immunol Methods 294: 199-207, 2004
45. Legardinier S, Legrand B, Raguénès-Nicol C, Bondon A, Hardy S, Tascon C, Le Rumeur E, Hubert J-F: A two-amino acid mutation encountered in Duchenne muscular dystrophy decreases stability of the rod domain 23 (R23) spectrin-like repeat of dystrophin. J Biol Chem 284: 8822-8832, 2009
46. Kusunoki H, Minasov G, Macdonald RI, Mondragón A: Independent movement, dimerization and stability of tandem repeats of chicken brain alpha-spectrin. J Mol Biol 344: 495-511, 2004
47. Aucouturier P, Bauwens M, Khamlichi AA, Denoroy L, Spinelli S, Touchard G, Preud'homme JL, Cogné M: Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J Immunol 150: 3561-3568, 1993